15 drugs reach their earliest generic-entry date in 2045

Jan 2045 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Epinephrine epinephrine	epinephrine	Fresenius Kabi Usa	215425	17 Jan 2045	patent

Feb 2045 · 2

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Rezdiffra · 3 strengths resmetirom	resmetirom	Madrigal	217785	4 Feb 2045	patent, carve-out possible
Lamlique · 2 strengths lamotrigine hemifumarate	lamotrigine hemifumarate	Azurity	221109	14 Feb 2045	patent

Mar 2045 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Symbravo meloxicam; rizatriptan benzoate	meloxicam; rizatriptan benzoate	Axsome	215431	10 Mar 2045	patent, carve-out possible

Apr 2045 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Kyxata · 2 strengths carboplatin	carboplatin	Avyxa Holdings	219921	1 Apr 2045	patent
Hyftor sirolimus	sirolimus	Nobelpharma	213478	11 Apr 2045	patent
Romvimza · 3 strengths vimseltinib	vimseltinib	Deciphera Pharms	219304	30 Apr 2045	patent

May 2045 · 2

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Enbumyst bumetanide	bumetanide	Corstasis Therap	219500	14 May 2045	patent
Lynkuet elinzanetant	elinzanetant	Bayer Hlthcare	219469	14 May 2045	patent, carve-out possible

Jun 2045 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Axtle · 2 strengths pemetrexed dipotassium	pemetrexed dipotassium	Avyxa Holdings	210661	25 Jun 2045	patent

Jul 2045 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Zunveyl · 3 strengths benzgalantamine gluconate	benzgalantamine gluconate	Alpha Cognition	218549	23 Jul 2045	patent, carve-out possible

Aug 2045 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Qlonilik clonidine hydrochloride	clonidine hydrochloride	Cmp Dev Llc	221094	22 Aug 2045	patent

Sep 2045 · 2

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Hemiclor chlorthalidone	chlorthalidone	Prm Pharma	218647	4 Sep 2045	patent
Vyscoxa celecoxib	celecoxib	Carwin Pharm Assoc	211759	17 Sep 2045	patent

Nov 2045 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Sernivo betamethasone dipropionate	betamethasone dipropionate	Primus Pharms	208079	19 Nov 2045	patent, carve-out possible